Steven C Gilman's Net Worth

$14.1 Million

Estimate Recalculated Nov 1, 2024 10:01AM EST

Who is Steven C Gilman

Steven C Gilman has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include Vericel Corp, CONTRAFECT Corp, Akebia Therapeutics, Inc., SCYNEXIS INC, CUBIST PHARMACEUTICALS INC, MOMENTA PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.

SEC CIK

Steven C Gilman's CIK is 0001379970

Past Insider Trading and Trends

2013 was Steven C Gilman's most active year for acquiring shares with 15 total transactions. Steven C Gilman's most active month to acquire stocks was the month of May. 2014 was Steven C Gilman's most active year for disposing of shares, totalling 26 transactions. Steven C Gilman's most active month to dispose stocks was the month of April. 2014 saw Steven C Gilman paying a total of $5,364,591.27 for 205,311 shares, this is the most they've acquired in one year. In 2015 Steven C Gilman cashed out on 309,954 shares for a total of $3,114,162.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vericel Corp

Investor
Updated Oct 18, 2024
Form 4
112.89%
5.83K
$27.21
-$165.13K
Oct 18, 2024
11.00K
Sell-Options
Oct 16
Form 4
83.33%
5.00K
$26.16
-$224.20K
Sep 05, 2024
11.00K
Sell-Options
Sep 04
Form 4
382.61%
17.60K
May 03, 2024
22.20K
Options
May 01
Form 4
11.20K
May 05, 2023
11.20K
Grant
May 03
Form 4
Apr 28, 2023
7.80K
Options
Apr 27
Form 4
-14.75%
-900.00
$30.94
-$27.85K
May 02, 2022
5.20K
Sale
ScheduledApr 29
Form 4
149.18%
9.10K
Apr 29, 2022
15.20K
Options
Apr 27
Form 4
-58.82%
-5.00K
$21.46
-$177.15K
Dec 01, 2021
3.50K
Sale
ScheduledNov 29
Form 4
-37.04%
-5.00K
$27.16
-$234.17K
Oct 28, 2021
8.50K
Sale
ScheduledOct 27
Form 4
-27.03%
-5.00K
$26.30
-$225.55K
Oct 01, 2021
13.50K
Sale
ScheduledSep 30
Form 4
260.00%
9.10K
Apr 30, 2021
12.60K
Options
Apr 28
Form 4
850.00%
14.88K
$14.56
-$25.48K
May 01, 2020
16.63K
Options
Apr 29
Form 4
98.33%
7.38K
$9.79
-$105.39K
May 03, 2019
14.88K
Sell-Options
ScheduledMay 01
Form 4
-50.00%
-7.50K
$10.39
-$114.43K
Mar 04, 2019
7.50K
Sale
ScheduledFeb 28
Form 4
-100.00%
-8.50K
$10.19
-$128.55K
Dec 04, 2018
Sale
ScheduledDec 03
Form 4
-51.43%
-9.00K
$7.33
-$84.60K
Sep 06, 2018
8.50K
Sale
ScheduledSep 04
Form 4
17.50K
May 03, 2018
17.50K
Grant
May 02
Form 4
17.50K
May 05, 2017
17.50K
Grant
May 03
Form 4
15.00K
May 06, 2016
15.00K
Grant
May 04
Form 3/A
Aug 28, 2015
Form 4
20.00K
Mar 24, 2015
20.00K
Grant
Mar 20
Form 3
Jan 07, 2015
Showing 22 results

CONTRAFECT Corp

CEO
Updated May 18, 2022
Form 4
42.00K
$3.35
$140.70K
May 18, 2022
42.00K
Grant
May 17
Form 4
25.00K
May 20, 2021
25.00K
Grant
May 18
Form 4
May 18, 2020
8.00K
Form 4
Aug 15, 2019
22.50K
Form 4
May 29, 2019
22.50K
Form 4
Feb 07, 2019
525.00K
Form 4
Feb 07, 2018
250.00K
Form 4
6.00%
1.20K
$0.63
$996.00
Jul 26, 2017
21.20K
Purchase
Jul 25
Form 4
Feb 03, 2017
315.00K
Form 4
40.00K
$1.25
$50.00K
Jul 27, 2016
40.00K
Purchase
Jul 27
Form 4
May 11, 2016
15.00K
Form 4
Mar 23, 2016
75.00K
Form 3
May 20, 2015
Showing 13 results

Akebia Therapeutics, Inc.

Investor
Updated Jun 10, 2024
Form 4
86.08%
75.00K
Jun 10, 2024
162.13K
Grant
Jun 06
Form 4
131.28%
75.00K
Jun 08, 2023
132.13K
Grant
Jun 06
Form 4
77.83%
33.80K
Jun 09, 2022
77.23K
Grant
Jun 08
Form 4
-9.52%
-4.57K
$0.36
-$1.65K
Jun 07, 2022
43.43K
Sale
ScheduledJun 03
Form 4
-8.69%
-4.57K
$3.32
-$15.16K
Jun 09, 2021
48.00K
Sale
ScheduledJun 07
Form 4
86.97%
33.80K
Jun 03, 2021
72.66K
Grant
Jun 02
Form 4
98.32%
29.23K
$12.08
-$55.17K
Jun 09, 2020
58.96K
Grant
ScheduledJun 05 - Jun 08
Form 4
24.24%
5.80K
$3.43
$19.89K
Nov 22, 2019
29.73K
Purchase
Nov 20
Form 4
330.37%
33.80K
Jun 10, 2019
44.03K
Grant
Jun 06
Form 4
87.63K
Dec 13, 2018
87.63K
Grant
Dec 12
Form 3
Dec 13, 2018
Showing 11 results

SCYNEXIS INC

Investor
Updated Jun 21, 2024
Form 4
191.67%
46.00K
Jun 21, 2024
70.00K
Grant
Jun 20
Form 4
71.43%
10.00K
Jun 23, 2023
24.00K
Grant
Jun 15
Form 4
10.00K
Jun 20, 2023
10.00K
Grant
Jun 15
Form 4
500.00%
20.00K
Jun 22, 2022
24.00K
Grant
Jun 17
Form 4
10.00K
Jun 21, 2021
10.00K
Grant
Jun 16
Form 4/A
55.00K
Mar 31, 2021
55.00K
Grant
Jul 06
Form 4
8.00K
$6.25
$25.00K
Dec 23, 2020
8.00K
Purchase
Dec 21
Form 4
45.00K
Jul 08, 2020
45.00K
Grant
Jul 06
Form 4
45.00K
Jun 20, 2019
45.00K
Grant
Jun 18
Form 4
22.50K
Jan 04, 2019
22.50K
Grant
Jan 02
Form 4
19.99K
Jan 04, 2018
19.99K
Grant
Jan 02
Form 4
1.81K
Oct 04, 2017
1.81K
Grant
Oct 02
Form 4
2.43K
Jul 05, 2017
2.43K
Grant
Jul 03
Form 4
1.68K
Apr 04, 2017
1.68K
Grant
Apr 03
Form 4
14.50K
Jan 05, 2017
14.50K
Grant
Jan 03
Form 4
1.31K
Jan 05, 2017
1.31K
Grant
Jan 03
Form 4
977.00
Oct 04, 2016
977.00
Grant
Oct 03
Form 4
2.03K
Jul 11, 2016
2.03K
Grant
Jul 01
Form 4
8.80K
$3.98
$35.02K
Jun 06, 2016
8.80K
Grant
Jun 02
Form 4
1.10K
Apr 05, 2016
1.10K
Grant
Apr 01
Form 4
729.00
Jan 06, 2016
729.00
Grant
Jan 04
Form 4
670.00
Oct 05, 2015
670.00
Grant
Oct 01
Form 4
502.00
Jul 06, 2015
502.00
Grant
Jul 01
Form 4
8.80K
Jun 05, 2015
8.80K
Grant
Jun 04
Form 4
554.00
Apr 03, 2015
544.00
Grant
Apr 01
Form 4
8.32K
Feb 27, 2015
8.32K
Grant
Feb 25
Form 3
Feb 27, 2015
Showing 27 results

CUBIST PHARMACEUTICALS INC

EVP & Chief Scientific Officer
Updated Jan 21, 2015
Form 4
-100.00%
-309.95K
$102.00
-$3.11M
Jan 21, 2015
Disposition
Jan 21
Form 4
0.30%
82.00
$59.96
$4.92K
Jan 05, 2015
30.53K
Acquisition
Dec 31
Form 4
-49.31%
-48.13K
$65.39
$1.00
Oct 02, 2014
52.32K
Sale
Oct 01
Form 4
-52.35%
-40.63K
$43.40
-$1.48M
Jul 29, 2014
39.82K
Sale
Jul 28
Form 4
3.90%
107.00
$69.82
$7.47K
Jul 02, 2014
30.45K
Acquisition
Jun 30
Form 4
-36.36%
-16.34K
$42.29
-$854.74K
May 15, 2014
31.34K
Sale
May 14 - May 15
Form 4
-5.33%
-1.68K
$69.00
-$115.92K
May 14, 2014
32.56K
Sale
May 13 - May 14
Form 4
4.22%
111.00
$73.15
$8.12K
Apr 02, 2014
27.24K
Acquisition
Mar 31
Form 4
91.38%
37.01K
$75.00
-$198.37K
Feb 19, 2014
80.14K
Sell-Options
Feb 14 - Feb 18
Form 4
-1.74%
-380.00
Jan 06, 2014
24.07K
Grant
Jan 02
Form 4/A
-22.61%
-26.24K
$43.31
-$1.22M
Jan 02, 2014
92.44K
Sale
Dec 23 - Jan 02
Form 4
-51.01%
-24.51K
$43.31
-$1.22M
Jan 02, 2014
26.17K
Sale
Dec 27 - Jan 02
Form 4
-2.48%
-585.00
Dec 20, 2013
25.68K
Grant
Dec 19
Form 4
1.09%
283.00
$42.49
$12.17K
Jul 02, 2013
26.27K
Acquisition
Jun 28
Form 4
-27.62%
-15.13K
$35.63
-$570.71K
Jun 03, 2013
42.11K
Sale
Jun 03
Form 4
-4.86%
-1.20K
$48.88
-$58.70K
May 17, 2013
25.99K
Sale
May 15 - May 16
Form 4
-3.95%
-1.02K
$48.41
-$49.24K
May 16, 2013
27.19K
Sale
May 14 - May 15
Form 4
-3.93%
-1.14K
$49.18
-$55.82K
May 15, 2013
30.20K
Sale
May 13 - May 14
Form 4
60.07%
167.00
$46.82
$7.82K
Apr 02, 2013
18.81K
Acquisition
Mar 28
Form 4
201.80%
62.24K
$41.40
-$51.05K
Feb 20, 2013
95.40K
Sell-Options
Feb 15 - Feb 19
Form 4
-26.68%
-14.86K
$30.90
-$359.82K
Jan 03, 2013
43.16K
Sale
Dec 31 - Jan 02
Form 4
-3.98%
-651.00
Aug 30, 2012
18.02K
Grant
Aug 29
Form 4
1.42%
289.00
$35.07
$10.15K
Jul 03, 2012
20.70K
Acquisition
Jun 29
Form 4
-25.52%
-20.00K
$30.13
-$457.67K
May 17, 2012
58.38K
Sale
May 17
Form 4
-7.11%
-1.60K
$41.88
-$66.88K
May 16, 2012
20.88K
Sale
May 14 - May 16
Form 4
-4.27%
-1.14K
$41.55
-$47.16K
May 15, 2012
25.48K
Sale
May 13 - May 14
Form 4
1.05%
131.00
$43.25
$5.67K
Apr 03, 2012
12.61K
Acquisition
Mar 30
Form 4
90.00K
Feb 21, 2012
90.00K
Grant
Feb 16
Form 4
-40.72%
-71.25K
$28.27
-$1.49M
Oct 28, 2011
103.73K
Sale
Oct 26
Form 4
0.09%
11.00
$35.32
$388.52
Oct 04, 2011
12.48K
Acquisition
Sep 30
Form 4
1.19%
147.00
$35.99
$5.29K
Jul 05, 2011
12.47K
Acquisition
Jun 30
Form 4
484.93%
84.00K
May 17, 2011
101.32K
Options
May 13 - May 15
Form 4
2.97%
211.00
$25.24
$5.33K
Apr 04, 2011
7.32K
Acquisition
Mar 31
Form 4
9.28%
604.00
$17.36
$10.48K
Jan 03, 2011
7.11K
Acquisition
Dec 31
Form 4
50.00K
Oct 19, 2010
50.00K
Grant
Oct 15
Form 4
0.71%
46.00
$23.39
$1.08K
Oct 04, 2010
6.51K
Acquisition
Sep 30
Form 4
15.40%
862.00
$17.41
$15.00K
Jul 02, 2010
6.46K
Acquisition
Jun 30
Form 4
1,668.24%
68.97K
$21.81
-$22.58K
May 18, 2010
73.10K
Sell-Options
May 14 - May 17
Form 4
5.65%
221.00
$22.54
$4.98K
Apr 01, 2010
4.13K
Acquisition
Mar 31
Form 4
10.88%
384.00
$15.10
$5.80K
Jan 04, 2010
3.91K
Acquisition
Dec 31
Form 4
2.08%
72.00
$20.20
$1.45K
Oct 01, 2009
3.53K
Acquisition
Sep 30
Form 4
22.42%
633.00
$16.71
$10.58K
Jul 02, 2009
3.46K
Acquisition
Jun 30
Form 4
72.50K
May 19, 2009
72.50K
Grant
May 15
Form 4
11.58%
293.00
$16.36
$4.79K
Apr 02, 2009
2.82K
Acquisition
Mar 31
Form 4
7.70%
181.00
$22.23
$4.02K
Oct 02, 2008
2.53K
Acquisition
Sep 30
Form 4
10.80%
229.00
$17.86
$4.09K
Jul 01, 2008
2.35K
Acquisition
Jun 30
Form 4
6.05%
121.00
$18.42
$2.23K
Apr 02, 2008
2.12K
Acquisition
Mar 31
Form 4
100.00K
Mar 17, 2008
100.00K
Grant
Mar 14
Form 3
Feb 14, 2008
2.00K
Showing 49 results

MOMENTA PHARMACEUTICALS INC

Investor
Updated Oct 01, 2020
Form 4
-100.00%
-77.86K
Oct 01, 2020
Disposition
Oct 01
Form 4
-62.51%
-13.00K
$21.69
-$287.56K
Aug 07, 2020
7.80K
Sale
ScheduledAug 05
Form 4
-32.47%
-10.00K
$20.17
-$190.70K
Jul 30, 2020
20.80K
Sale
ScheduledJul 29
Form 4
-24.51%
-10.00K
$21.93
-$226.00K
Jul 23, 2020
30.80K
Sale
ScheduledJul 22
Form 4
25.00K
Jun 24, 2020
25.00K
Grant
Jun 23
Form 4
320.68%
25.00K
Jun 21, 2019
32.80K
Options
Jun 19 - Jun 20
Form 4
-40.01%
-2.29K
$21.50
-$49.32K
Jun 26, 2018
3.44K
Sale
ScheduledJun 22
Form 4
230.40%
13.21K
Jun 22, 2018
18.95K
Options
Jun 20
Form 4
16.94K
Jun 22, 2017
16.94K
Grant
Jun 20
Form 4
33.00K
Jun 24, 2016
33.00K
Grant
Jun 22
Form 3
Jun 24, 2016
Showing 11 results

KERYX BIOPHARMACEUTICALS INC

Investor
Updated Dec 13, 2018
Form 4
-100.00%
-167.33K
Dec 13, 2018
Disposition
Dec 12
Form 4
230.77%
40.00K
Jul 12, 2018
57.33K
Grant
Jun 30
Form 4
-7.15%
-1.33K
$5.12
-$6.83K
Jun 12, 2018
17.33K
Sale
ScheduledJun 11
Form 4
-6.66%
-1.33K
$5.22
-$6.96K
May 31, 2018
18.67K
Sale
ScheduledMay 29
Form 4
400.00%
40.00K
Jun 20, 2017
50.00K
Grant
Jun 09
Form 4
40.00K
May 27, 2016
40.00K
Grant
May 26
Form 3
Apr 08, 2016
Showing 7 results